IGUAKO Capital is a work of institutional fiction by the Iguako Institute for Applied Unreality. No financial services are offered, no accounts exist and nothing here is an offer, a contract or advice.About this work
George Town · 36 cities · English Domiciles Documents Iguako Network Site Index

The Firm

Leadership

A Board of seven directors, four of them independent, and an Executive Committee of nine. Biographies, bases and areas of focus.

Board
7
Independent
4
Executive Committee
9
Founding partners
3

Board of Directors

Seven directors.

Marguerite Aldous-Kerr

Chair of the Board · Brisbane · joined 2019

Marguerite Aldous-Kerr is one of the two founding partners of IGUAKO Capital and has chaired the Board since the holding company was formed in George Town in 2019. She trained as a veterinary pharmacologist in Queensland and spent twenty-four years in animal health, latterly as managing director of a vaccine manufacturer supplying cattle, sheep and aquaculture producers across Australia and South-East Asia. She sold that business in 2016.

She sets the Board calendar, leads the succession review for every executive appointment and holds the relationship with the co-investors who own minority interests in the group. She chairs the Remuneration Committee and took the Ethical Technology Charter to the Board in 2023, with welfare in biological capital written into it as a principle rather than left to a policy. She works from Eagle Street House in Brisbane and sits in George Town each quarter.

Board composition and successionAnimal health and veterinary biologics originationRemuneration and partner alignment

Tobias Renfield-Oyelaran

Chief Executive · Palm Beach · joined 2019

Tobias Renfield-Oyelaran is the second founding partner and has been Chief Executive since 2019. He began in pharmaceutical distribution in Florida, running the specialty and cold-chain arm of a regional distributor, and moved into finance as treasurer of a contract manufacturer of sterile injectables. He then spent seven years running a private investment partnership in Palm Beach that took control positions in pharmaceutical services companies and realised four of them.

He chairs the Executive Committee and owns the four underwriting tests that govern every movement of capital. His working rule is that the origination business and the deployment business are separate in execution and single in purpose. He divides the year between Worth Avenue Pavilion in Palm Beach and Harbourfront Chambers in George Town, and visits each regional hub at least once in every eighteen months.

Group strategy and capital allocationPharmaceutical services originationExecutive appointments and division leadership

Ines Castellane-Whitlock

Chief Investment Officer · George Town · joined 2019

Ines Castellane-Whitlock has been Chief Investment Officer since the group was formed and works from Harbourfront Chambers in George Town. She underwrote specialty credit for a reinsurance group in Bermuda for nine years, then built and ran a royalty book secured on approved pharmaceutical products. That book taught her to price the difference between a structural advantage and a temporary one, which is the first of the four underwriting tests.

She chairs the Investment Committee and is accountable for the 47 portfolio companies and positions held across the six divisions at 30 June 2026. She approves the reallocation of proceeds out of the origination sectors and into information infrastructure, structured credit and quantitative markets. She reads every valuation paper before the Risk and Valuation Committee sits, and she signs the marks on unquoted positions.

Capital allocation across the six divisionsPharmaceutical and animal-health originationRealisations and reinvestmentValuation of unquoted positions

Halvard Brennan-Osei

Independent Director · Hamilton · joined 2021

Halvard Brennan-Osei joined the Board as an independent director in 2021 and sits in Hamilton. He spent thirty-one years in reinsurance: first as a property and casualty underwriter, then as chief underwriting officer of a Bermudian reinsurer, and finally as the executive who built its insurance-linked securities platform. He has underwritten catastrophe risk through four hard markets and retired from that business in 2020.

He brings the discipline of a reinsurer to the question of how much loss the group is prepared to accept, which is the fourth underwriting test. He reviews the insurance-linked and reinsurance vehicles registered in Bermuda and reports on them to the Board. He sits on the Audit Committee, the Risk and Valuation Committee and the Remuneration Committee, and he holds no executive role and no operating mandate anywhere in the group.

Reinsurance and insurance-linked vehiclesRisk appetite and loss toleranceAudit and valuation oversight

Yumiko Sandoval-Reyes

Independent Director · Tokyo · joined 2024

Yumiko Sandoval-Reyes joined the Board as an independent director in 2024 and works from Otemachi Chambers in Tokyo. She spent twenty-two years in pharmaceutical regulatory affairs, latterly as regulatory-affairs director for a manufacturer of injectable and biologic medicines with plants in Japan and Mexico. She then spent four years as head of quality for a veterinary biologics business selling into South-East Asia.

She reads the group as a supervisor would: what was filed, what was inspected and what the file will look like in five years. She reviews every life-science position for welfare and manufacturing standards before the Investment Committee commits to it. She sits on the Audit Committee, the Compliance and Conduct Committee and the Ethics and Technology Council, and she keeps her Tokyo base because the pharmaceutical relationships there are long ones.

Pharmaceutical manufacturing and quality standardsWelfare in biological capitalCompliance and conduct oversight

Cormac Delacroix-Nwosu

Independent Director · Luxembourg · joined 2022

Cormac Delacroix-Nwosu joined the Board in 2022 as an independent director and chairs the Audit Committee from Grand-Rue Chambers in Luxembourg. He worked for nineteen years as an economist at a national central bank, running monetary analysis and later the oversight of payment and settlement systems. He left to become chief economist of a European fund platform, where he stayed for six years.

He asks the arithmetic questions: what the accounts assume, what the assumption is worth if the rate cycle turns, and where a number came from. He sets the internal audit plan with the Chief Operating Officer, recommends the annual accounts to the Board and sits on the Remuneration Committee. Twice a year he meets the independent valuation reviewers with no executive present.

Audit and the annual accountsFunding, liquidity and the rate cycleInternal audit planning

Priya Vantongeren

Independent Director · Toronto · joined 2023

Priya Vantongeren joined the Board in 2023 as an independent director and chairs the Information Governance Committee from Bay-Wellington House in Toronto. She built the data protection and provenance function for a health-data business operating in eleven countries. She then spent five years advising private-markets managers on lawful bases, retention schedules and cross-border transfer.

Her standing test is whether a dataset can show where it came from and under what lawful basis it is held. She wrote the provenance principle of the Ethical Technology Charter with the Head of Technology and Ethics. She reviews the register of datasets held by the Information and Data division each quarter, and she sits on the Audit and Remuneration Committees and on the Ethics and Technology Council.

Data provenance and lawful basisRecords retention and cross-border transferModel governance oversight

Executive Committee

Nine executives.

Tobias Renfield-Oyelaran

Chief Executive · Palm Beach · joined 2019

Tobias Renfield-Oyelaran is the second founding partner and has been Chief Executive since 2019. He began in pharmaceutical distribution in Florida, running the specialty and cold-chain arm of a regional distributor, and moved into finance as treasurer of a contract manufacturer of sterile injectables. He then spent seven years running a private investment partnership in Palm Beach that took control positions in pharmaceutical services companies and realised four of them.

He chairs the Executive Committee and owns the four underwriting tests that govern every movement of capital. His working rule is that the origination business and the deployment business are separate in execution and single in purpose. He divides the year between Worth Avenue Pavilion in Palm Beach and Harbourfront Chambers in George Town, and visits each regional hub at least once in every eighteen months.

Group strategy and capital allocationPharmaceutical services originationExecutive appointments and division leadership

Ines Castellane-Whitlock

Chief Investment Officer · George Town · joined 2019

Ines Castellane-Whitlock has been Chief Investment Officer since the group was formed and works from Harbourfront Chambers in George Town. She underwrote specialty credit for a reinsurance group in Bermuda for nine years, then built and ran a royalty book secured on approved pharmaceutical products. That book taught her to price the difference between a structural advantage and a temporary one, which is the first of the four underwriting tests.

She chairs the Investment Committee and is accountable for the 47 portfolio companies and positions held across the six divisions at 30 June 2026. She approves the reallocation of proceeds out of the origination sectors and into information infrastructure, structured credit and quantitative markets. She reads every valuation paper before the Risk and Valuation Committee sits, and she signs the marks on unquoted positions.

Capital allocation across the six divisionsPharmaceutical and animal-health originationRealisations and reinvestmentValuation of unquoted positions

Aurelio Marchbanks-Tan

Chief Financial Officer · George Town · joined 2020

Aurelio Marchbanks-Tan became Chief Financial Officer in 2020 and works from Harbourfront Chambers in George Town. He was group treasurer of a specialty materials manufacturer with plants in three countries, where he refinanced the group twice, and then finance director of a private credit platform lending to mid-market pharmaceutical suppliers. He qualified as an accountant in Singapore and has worked in four currencies since.

He is responsible for the proprietary balance sheet of US$610 million, for the US$215 million of committed but undrawn facilities and for the accounts of every registered entity in the group. He runs the Caribbean treasury build that opens Programme Latitude in 2026. He sits on the Investment Committee, the Risk and Valuation Committee, the Expansion Committee and the Compliance and Conduct Committee.

Balance sheet, treasury and fundingGroup and entity accountsFacilities and counterparty credit lines

Sable Okonjo-Lindqvist

Chief Operating Officer · Luxembourg · joined 2021

Sable Okonjo-Lindqvist has been Chief Operating Officer since 2021 and works from Grand-Rue Chambers in Luxembourg. She spent eleven years in fund administration, latterly running operations for a European fund platform with vehicles in three domiciles, and before that she built a transfer agency team from four people to sixty. She has opened offices in five countries and closed one.

She owns the operating model: the service catalogue for each office, the outsourcing register, the resilience testing calendar and the workforce plan that takes the group from 312 people to 480 by 2032. She turns an approved phase of Programme Latitude into leases, licences, systems and staff. She sits on the Executive, Expansion, Risk and Valuation and Information Governance Committees.

Operating model and service catalogueOffice openings and operational resilienceOutsourcing and third-party oversight

Fenella Marsh-Adeyemi

General Counsel and Group Head of Compliance · London · joined 2020

Fenella Marsh-Adeyemi joined in 2020 as General Counsel and Group Head of Compliance and works from Bishopsgate Court in London. She practised as a regulatory lawyer for twelve years, advising private-markets firms on perimeter, financial promotion and cross-border services. She then spent six years as head of financial crime for a private bank with booking centres in three regions.

She owns the forty group policies, the local variations that each domicile requires and the register of permissions across 28 jurisdictions. She chairs the Compliance and Conduct Committee and takes every report made to the whistleblowing mailbox to the Audit Committee in a form that identifies nobody. No jurisdiction is added to the group until she has approved the perimeter analysis for it.

Policy framework and local variationsFinancial crime and sanctionsPerimeter and cross-border servicesWhistleblowing and investigations

Dmitri Halloran-Veiga

Chief Risk Officer · Zürich · joined 2022

Dmitri Halloran-Veiga became Chief Risk Officer in 2022 and works from the Paradeplatz Annex in Zürich. He ran market and credit risk for a private bank in Switzerland for eight years and, before that, built capital models for a reinsurance underwriter in Bermuda. He has spent his career on two questions: what a position is worth today, and what it does under stress tomorrow.

He chairs the Risk and Valuation Committee, drafts the risk appetite statement that the Board approves each year and maintains the limit framework for the six divisions. He runs the quarterly valuation review of the 47 positions and the standing stress that assumes an exit window closed for eighteen months. Every limit breach goes to the Board with his assessment attached.

Risk appetite and limitsValuation of unquoted positionsStress testing and liquidity risk

Ottoline Baskerville-Nakamura

Head of Technology and Ethics · Singapore · joined 2022

Ottoline Baskerville-Nakamura joined in 2022 as Head of Technology and Ethics and works from Raffles Quay Pavilion in Singapore. She spent nine years as a data engineer and then as head of model risk for a data analytics business serving agricultural and marine producers. She has built provenance records for datasets covering more than two hundred thousand animal holdings across four continents.

She drafted the Ethical Technology Charter that the Board adopted in 2023 and chairs the Ethics and Technology Council that oversees it. She keeps the model inventory for the Quantitative Strategies and Information and Data divisions, and she names the person accountable for each automated step. No client decision anywhere in the group is made by a model, and any client may require a human review.

The Ethical Technology CharterModel inventory and model riskData provenance and engineeringTechnology in the two model-using divisions

Rafael Quintero-Blyth

Head of Expansion · Panama City · joined 2022

Rafael Quintero-Blyth joined in 2022 as Head of Expansion and works from the Cinta Costera Tower in Panama City. He spent fourteen years in trade finance and correspondent banking across Latin America and the Caribbean, latterly as the executive who opened four country offices for a regional commercial lender. He has negotiated entity licensing in nine jurisdictions and withdrawn from two.

He runs Programme Latitude, the seven-phase build from 2026 to 2032 that takes the group to 40 jurisdictions, 50 offices and representative desks and 480 people. He chairs the Expansion Committee and brings each phase gate to the Board with its cost, its licensing timetable and its exit. The programme carries US$180 million of investment, funded entirely from realised proceeds.

Programme Latitude and its phase gatesJurisdiction licensing and entity establishmentCorrespondent and counterparty relationships

Beatrix Oduya-Ferrante

Head of Private Wealth · Nassau · joined 2021

Beatrix Oduya-Ferrante has led Private Wealth and UHNW since 2021 and works from the Bay Street Pavilion in Nassau. She spent seventeen years in private wealth, running a booking centre in the Bahamas and then a family governance practice that advised founders on succession, trust structures and the sale of a controlled business. She read law before she read markets.

She holds the 61 family relationships of the group and the mandates behind them, from consolidated reporting for a single family to co-investment alongside the Private Equity division. Most of her clients sold companies in the sectors the group originates in, so the arithmetic is familiar to them. She sits on the Investment Committee, the Expansion Committee and the Compliance and Conduct Committee.

Family relationships and mandatesSuccession and trust structuresCo-investment alongside the divisions